Search Results 3241-3250 of 42555 for oral

  1. Sleep disorders - Doctors and departments - Mayo Clinic

    Dental surgery, Oral surgery, Oral appliance therapy, Dental exam for children, Oral biopsy, Oral cancer screening, Den...tal cleaning, Dental cavities ...

  2. A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers - Mayo Clinic

    retinoids, biologic agents, oral calcineurin inhibitors; high potency or oral steroids) - Patients with history Guillain-Barre syndrome or myasthenia gravis ...

  3. Leukoplakia - Doctors and departments - Mayo Clinic

    ... Oral ulcerative condition, Facial volume loss. Show more areas of focus for Alison J. Bruce, M.B., Ch.B. By Mayo Clinic Staff · Request an appointment.

  4. Penciclovir (topical route) - Side effects & dosage - Mayo Clinic

    Topical penciclovir is used to treat the symptoms of herpes simplex virus infections around the mouth (cold sores). Although topical penciclovir will not cure ...

  5. Cardiac Catheterization Clinical Trials - Mayo Clinic Research

    The purpose of this study is to answer the question: “Does a short course of oral anticoagulation with a direct oral anticoagulant after transradial access ...

  6. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  7. Sarcoma - Doctors and departments - Mayo Clinic

    Areas of focus: Radiation therapy, Proton therapy, Stereotactic body radiotherapy, Intensity-modulated radiation therapy, Oral and thro...at cancer, Head ...

  8. Tongue cancer - Doctors and departments - Mayo Clinic

    Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...

  9. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Oral 5-aminosalicylate (5-ASA) compounds provided the dose prescribed has been stable for at least 4 weeks prior to randomization; dose must remain stable ...

  10. Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis - Mayo Clinic

    Treatment with >1 IV dose of cyclophosphamide and/or >14 days of oral cyclophosphamide and/or >14 days of prednisone/prednisolone (>30 mg/day) and/or >1 ...